School of Medicine
Showing 201-300 of 523 Results
-
Christina Kong
Professor of Pathology
Current Research and Scholarly InterestsImproving the accuracy of cytologic diagnosis through the use of ancillary techniques on specimens obtained by fine needle aspiration biopsy.
Identifying potential indicators of prognosis in head and neck squamous cell carcinomas.
Evaluating the utility of immunohistochemical stains in refining the diagnosis of squamous dysplasia of the cervix, vulva, and head and neck. -
Christian Kunder
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy main interest is in understanding the biology of human neoplasms, using traditional histopathology, molecular genetic techniques, and other modalities. In particular, I am interested in soft tissue and genitourinary neoplasms, especially prostate cancer.
I am also interested in the classification and nomenclature of neoplasms and in practical research that helps us refine these, using a variety of techniques but still principally guided by histopathology.
I also work on developing next generation sequencing-based tests for genotyping tumors and in expanding the scope of this testing with the goal of identifying patients eligible for novel targeting therapies. -
Masako Lien Petty Le-Maciukiewicz, MD, MSc
Affiliate, Pathology VA Faculty PTAs
BioMy research is centered on neurodegenerative and ocular diseases, with a focus on the unfolded protein response, specifically the PERK pathway. Through my work, I investigate the cellular mechanisms underlying diseases like Alzheimer's and advanced tauopathies, with an emphasis on mitochondrial dysfunction and ER stress.
As I continue to deepen my understanding of disease pathology, I am also pursuing a residency in pathology (ECFMG-Certified, AAMC: 14765627), with a particular interest in neuropathology and forensic pathology. Alongside my primary research, I have been involved in a forensic pathology project, applying my skills from my previous studies in forensic science, further exploring my passion for understanding disease processes and the human body through both clinical and investigative lenses.
In addition to my research and forensic work, I have enjoyed shadowing in clinical settings, which has reinforced my commitment to a career in pathology. -
Joseph (Joe) Lipsick
Professor of Pathology and of Genetics
Current Research and Scholarly InterestsFunction and evolution of the Myb oncogene family; function and evolution of E2F transcriptional regulators and RB tumor suppressors; epigenetic regulation of chromatin and chromosomes; cancer genetics.
-
Amy Lo
Adjunct Clinical Associate Professor, Pathology
BioDr. Amy Lo is a pathologist with board certification in anatomic pathology, clinical pathology and molecular genetic pathology. She completed her MD and MS at the University of Illinois at Chicago and her residency in both anatomic and clinical pathology at Northwestern University. She then joined the faculty at Northwestern University as a Clinical Instructor and Advanced Gastrointestinal/Surgical Pathology Fellow. Amy then completed a molecular genetic pathology fellowship at Stanford University.
In 2016, Amy joined Genentech as research pathology scientist supporting drug research and development with a focus in oncology and individualized drug development.
Additionally, Amy continues clinical work as an Adjunct Clinical Associate Professor in pathology at Stanford University and Lucille Packard’s Children’s Hospital. -
Avinash Londhe
Postdoctoral Scholar, Pathology
BioDr. Avinash Londhe is a postdoctoral researcher in Dr. Katrin Svensson’s lab in the Department of Pathology at Stanford University, where he investigates the complex mechanisms linking cancer, metabolism, and obesity. His research focuses on understanding how orphan peptide hormones regulate metabolic pathways and identifying novel receptor-peptide interactions. Driven by a passion for translational science, Dr. Londhe is committed to translating fundamental discoveries into real-world solutions that improve patient outcomes.
During his doctoral training in Dr. Benoit Boivin’s lab at SUNY Polytechnic Institute, Dr. Londhe gained in-depth expertise in molecular mechanisms underlying metabolic disorders and cancer. His work contributed to the development of therapeutic strategies aimed at metabolic dysfunction. In addition to research, he excelled at managing laboratory operations and mentoring both graduate and undergraduate students, fostering a dynamic and collaborative research environment.
Currently, Dr. Londhe is broadening his research toolkit by integrating bioinformatics, molecular biology, and biophysical techniques into his experimental approaches. His goal is to address critical challenges in cancer metabolism and metabolic diseases through innovative research.
Dr. Londhe aspires to secure a faculty position at a leading university, where he can advance impactful research, mentor emerging scientists, and continue driving scientific innovation. -
Jonathan Z. Long
Associate Professor of Pathology
BioDr. Jonathan Long is an Associate Professor of Pathology and an Institute Scholar of Stanford ChEM-H (Chemistry, Engineering & Medicine for Human Health). His laboratory studies signaling pathways in mammalian energy metabolism. The long-term goal of this program is to discover new molecules and pathways that can be translated into therapeutic opportunities for obesity, metabolic disease, and other age-associated chronic diseases. Work from the laboratory has been recognized by numerous awards from the Alfred P. Sloan Foundation, the National Institutes of Health, the American Diabetes Association, and the Ono Pharma Foundation. Prior to arriving to Stanford, Dr. Long completed his Ph.D. in Chemistry at Scripps Research and his postdoctoral work at Harvard Medical School.
-
Teri A Longacre
Richard L. Kempson, MD, Professor in Surgical Pathology
Current Research and Scholarly InterestsGynecological, breast and gastrointestinal pathology with major emphasis on ovarian cancer and ovarian tumors of low malignant potential. Pathology of familial and hereditary breast-ovarian-GI cancer.
-
Alarice Cheng-Yi Lowe
Associate Professor of Pathology
BioDr. Lowe joined the School of Medicine faculty in 2019. She received her undergraduate degree in Biology from MIT and her medical degree at UCSD, prior to residency and cytology fellowship at UCLA. In 2011, she joined the faculty at Brigham and Women's Hospital where she developed a research focus on Circulating Tumor Cells (CTCs) and the application of new technology to improve clinical and molecular diagnostics. Clinically, her interests focus on Cytopathology and Genitourinary Pathology.
-
Bingwei Lu
Professor of Pathology
Current Research and Scholarly InterestsWe are interested in understanding how neural stem cells balance their self-renewal and differentiation and how deregulation of this process can result in brain tumor. We are also interested in mechanisms of neurodegeneration in Alzheimers and Parkinsons diseases. We are using both Drosophila and mammalian models to address these fundamental questions.
-
Ruben Y. Luo
Assistant Professor of Pathology
Current Research and Scholarly InterestsApply top-down mass spectrometry and label-free immunoassay to the study and utilization of biomarker proteoforms in clinical diagnosis.
-
Morgan Mann
Postdoctoral Scholar, Pathology
BioMorgan W. Mann, PhD, is a postdoctoral researcher at Stanford University and clinical chemistry DABCC fellow at the University of California – San Francisco (UCSF). His personal and professional interests involve the development of novel clinical assays to streamline medical diagnostics and address emerging challenges to our healthcare systems. Prior to his joint positions at Stanford and UCSF, Morgan earned his PhD in Cellular and Molecular Pathology at the University of Wisconsin – Madison, where he applied mass spectrometry-based proteomics to study innate inflammation signaling pathways and viral protein structure in the context of airway infection. He received dual bachelor’s degrees in Biochemistry and Mathematics from the University of Oklahoma.
-
Magdalena Matusiak
Instructor, Pathology
Current Research and Scholarly InterestsMy research focuses on revealing clinically relevant prognostic markers associated with myeloid cell biology in solid malignancies. I currently. lead two main projects: first, using single-cell RNA Sequencing and bulk tissue genomics to discover tumor-associated macrophage (TAM) diversity and establish their prognostic and predictive markers, second: using multiplex tissue imaging (MIBI) to unravel prognostic markers of spatial heterogeneity in the colon cancer.
-
Joshua Menke
Clinical Assistant Professor, Pathology
BioDr. Joshua Menke completed his hematopathology fellowship at Stanford and a cytopathology fellowship at the University of California, San Francisco (UCSF). His clinical and research interests lie at the intersection of hematopathology, cytopathology, and advanced single-cell and cell-free diagnostic techniques. As the Associate Section Director of Clinical Flow Cytometry at Stanford, Dr. Menke is developing and validating new minimal residual disease assays for detecting low levels of myeloid and lymphoid neoplasms in the post-treatment setting, as well as multiple other 12-color flow assays with the latest markers for routine phenotyping.
Dr. Menke is the recipient of the Paul E. Strandjord Young Investigator Award from the Academy of Clinical Laboratory Scientists and the Laurence J. Marton Award for Excellence in Research from UCSF for his translational work on CALR mutations at the UCSF Molecular Diagnostics Laboratory. Dr. Menke is a founding member of the Cytology-Hematopathology Interinstitutional Collaboration (CHIC), which aims to study the performance of cytology samples in diagnosing lymphoma across large datasets from five academic institutions. He currently chairs this group, leading large clinical research studies. -
Sara Michie
Professor of Pathology (Research), Emerita
Current Research and Scholarly InterestsLymphocyte/endothelial cell adhesion mechanisms involved in lymphocyte migration to sites of inflammation; regulation of expression of endothelial cell adhesion molecules.
-
Michelle M. Miranda Vélez
Postdoctoral Scholar, Pathology
BioMichelle Miranda (she/her) is a postdoctoral scholar in the Dodd Lab in the Pathology Department. Her research interest lies in bridging science and medicine by implementing core chemistry to study and improve human health.
-
Paul Salomon Mischel
Fortinet Founders Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy research bridges cancer genetics, signal transduction and cellular metabolism as we aim to understand the molecular mechanisms that drive cancer development, progression, and drug resistance. We have made a series of discoveries that have identified a central role for ecDNA (extrachromosomal DNA) in cancer development, progression, accelerated tumor evolution and drug resistance.
-
Maneesh Kumar Misra
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy research goal is to utilize the cutting edge of stat of art histocompatibility testing to better understand the humoral and cellular responses in clinical transplantation, and to translate this knowledge into improved treatment, and transplant outcome.
-
Michelle Monje
Milan Gambhir Professor of Pediatric Neuro-Oncology and Professor, by courtesy, of Neurosurgery, of Pediatrics, of Pathology and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states.
-
Stephen B. Montgomery
Stanford Medicine Professor of Pathology, Professor of Genetics and of Biomedical Data Science
Current Research and Scholarly InterestsWe focus on understanding the effects of genome variation on cellular phenotypes and cellular modeling of disease through genomic approaches such as next generation RNA sequencing in combination with developing and utilizing state-of-the-art bioinformatics and statistical genetics approaches. See our website at http://montgomerylab.stanford.edu/
-
Thomas Montine, MD, PhD
Stanford Medicine Professor of Pathology
BioDr. Montine received his education at Columbia University (BA in Chemistry), the University of Rochester (PhD in Pharmacology), and McGill University (MD and CM). His postgraduate medical training was at Duke University, and he was junior faculty at Vanderbilt University where he was awarded the Thorne Professorship in Pathology. In 2002, Dr. Montine was appointed as the Alvord Endowed Professor in Neuropathology and Director of the Division of Neuropathology at the University of Washington. He was Director of the University of Washington Alzheimer’s Disease Research Center, one of the original 10 Centers in the US, and passed that responsibility to able colleagues. Dr. Montine was the founding Director of the Pacific Udall Center, a NINDS-funded Morris K. Udall Centers of Excellence for Parkinson’s Disease Research. In 2010, Dr. Montine was appointed Chair of the Department of Pathology at the University of Washington. In 2016, Dr. Montine was appointed Chair of the Department of Pathology at Stanford University where he is the Stanford Medicine Endowed Professor in Pathology.
The focus of the Montine Laboratory is on the structural and molecular bases of cognitive impairment. The Montine Laboratory addresses this prevalent, unmet medical need through a combination of neuropathology, biomarkers for detection and progression of early disease, and experimental studies that test hypotheses concerning specific mechanisms of neuron injury and then develop novel approaches to neuroprotection. Our current approaches include small molecule precision therapeutics and cell replacement strategies for brain. -
Saisindhu Narala, MD, MAS
Clinical Assistant Professor, Dermatology
Clinical Assistant Professor, PathologyBioDr. Narala completed her dermatology residency at the University of Texas at Houston and MD Anderson Cancer Center. She then completed a fellowship in dermatopathology at Stanford. Her clinical interests include general medical dermatology, dermatology in skin of color, and pigmentary disorders. She also has an interest in medical education.
-
Yasodha Natkunam, M.D., Ph.D
Ronald F. Dorfman, MBBch, FRCPath Professor of Hematopathology
Current Research and Scholarly InterestsMy research interests focus on the identification and characterization of markers of diagnostic and prognostic importance in hematolymphoid neoplasia.
-
Shaghayegh Navabpour
Postdoctoral Scholar, Pathology
Current Research and Scholarly InterestsMy research interests lie at the intersection of genetics and epigenetics, with a current focus on cancer and drug development. I am particularly interested in bifunctional small molecules, such as Transcriptional/Epigenetic Chemical Inducers of Proximity (TCIPs). My work now concentrates on designing, synthesizing, and testing new TCIPs that utilize various transcription factors or histone modifiers to target genes implicated in different types of cancer. Through this approach, I aim to develop innovative therapies that can more precisely and effectively combat cancer, especially to ease the treatment process for vulnerable patients, such as children and adolescents.